Doximity (DOCS) Net Income towards Common Stockholders (2020 - 2026)

Doximity (DOCS) has reported Net Income towards Common Stockholders for 7 consecutive years, with $19.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 69.4% year-over-year to $19.1 million; the TTM figure through Mar 2026 stood at $196.1 million (down 12.16% YoY), while the FY2026 annual figure was $196.1 million, down 12.16% from the prior year.
• Net Income towards Common Stockholders declined to $19.1 million in Q1 2026 per DOCS's latest filing, from $61.6 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $75.2 million in Q4 2024 and bottomed at $19.1 million in Q1 2026.
• Historically, Net Income towards Common Stockholders has averaged $42.2 million across 5 years, with a median of $40.6 million in 2024.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 245.25% — and 2026, when it plunged 69.4%.
• Doximity's Net Income towards Common Stockholders stood at $33.5 million in 2022, then soared by 43.29% to $48.0 million in 2023, then soared by 56.8% to $75.2 million in 2024, then slipped by 18.14% to $61.6 million in 2025, then sank by 68.95% to $19.1 million in 2026.
• Business Quant data shows DOCS's Net Income towards Common Stockholders at $19.1 million in Q1 2026, $61.6 million in Q4 2025, and $62.1 million in Q3 2025.